ELMO3 predicts poor outcome in T1 laryngeal cancer.
Georg HaymerleL KadletzR WiebringhausB GolabiM MildnerD ThurnherG HeiduschkaPublished in: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery (2017)
This is the first study to show a prognostic effect of positive ELMO3 expression in early glottic carcinoma patients.